Qysmia Diet Drug Hits Market Amid Pregnancy Risks, Other Concerns
The new weight loss drug Qsymia was introduced to the market this week, despite the risk of birth defects from topiramate, one of the active ingredients, and other safety concerns…
Tag Archives: Qnexa
-
-
Qnexa Diet Pill Approval Delayed in Face of New Safety Plan
Federal drug regulators have decided to delay a decision on whether to approve the weight loss drug Qnexa, which includes the active ingredient of Topamax and one of the active…
-
Despite Risk of Birth Defects from Topiramate, FDA Panel Approves Diet Drug
An FDA panel of outside advisors has given the nod to a new weight loss drug developed by Vivus, Inc., which was was previously rejected due to concerns over the…
-
Topamax Cleft Palate Problems May Impact New Weight Loss Drug
It appears that concerns about the risk of birth defects from use of Topamax (topiramate) during pregnancy may impact a new proposed diet drug that combines the epilepsy medication with…
